HEALY JAMES

Transactions récentes

…

InsiderLens

USPersonne physique

HEALY JAMES

Transactions totales: 425
Entreprises: 21
Achats / Ventes: 58 / 37
Dernière transaction: 16 sept. 2025

Transactions récentes

16 sept. 2025TENDERY-mAbs Therapeutics, Inc.31 6038.60 USD
détention directe
16 sept. 2025TENDERY-mAbs Therapeutics, Inc.2 194 2788.60 USD
indirect· See footnote
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.25 080—
détention directe
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.33 450—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.16 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.13 950—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.8 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.14 545—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.11 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.11 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.14 222—
détention directederiv
30 juin 2025GRANT_AWARDY-mAbs Therapeutics, Inc.25 0800.00 USD
détention directe
30 juin 2025GRANT_AWARDY-mAbs Therapeutics, Inc.33 4500.00 USD
détention directederiv
17 juin 2025GRANT_AWARDRapport Therapeutics, Inc.21 8500.00 USD
détention directederiv
05 juin 2025GRANT_AWARDBioAge Labs, Inc.22 0000.00 USD
détention directederiv
25 avr. 2025GRANT_AWARDNatera, Inc.142—
détention directe
31 janv. 2025GRANT_AWARDNatera, Inc.114—
détention directe
25 oct. 2024GRANT_AWARDNatera, Inc.153—
détention directe
27 sept. 2024CONVERSIONBioAge Labs, Inc.1 638 236—
indirect· Sofinnova Venture Partners XI, L.P.
27 sept. 2024PURCHASEBioAge Labs, Inc.588 88818.00 USD
indirect· Sofinnova Venture Partners XI, L.P.
27 sept. 2024PURCHASEBioAge Labs, Inc.26 49718.00 USD
indirect· CRESTLINE SUMMIT PINNACLE MASTER, L.P.
27 sept. 2024PURCHASEBioAge Labs, Inc.18 35318.00 USD
indirect· CRESTLINE SUMMIT MASTER, SPC - CRESTLINE SUMMIT APEX SP
27 sept. 2024PURCHASEBioAge Labs, Inc.21 81418.00 USD
indirect· Crestline Summit Master, SPC - PEAK SP
27 sept. 2024PURCHASEBioAge Labs, Inc.11 11318.00 USD
indirect· Sofinnova Synergy Master Fund LP
27 sept. 2024CONVERSIONBioAge Labs, Inc.7 310 796—
indirect· Sofinnova Venture Partners XI, L.P.deriv

…

16 sept. 2025TENDERY-mAbs Therapeutics, Inc.31 6038.60 USD
détention directe
16 sept. 2025TENDERY-mAbs Therapeutics, Inc.2 194 2788.60 USD
indirect· See footnote
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.25 080—
détention directe
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.33 450—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.16 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.13 950—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.8 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.14 545—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.11 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.11 000—
détention directederiv
16 sept. 2025OTHERY-mAbs Therapeutics, Inc.14 222—
détention directederiv
30 juin 2025GRANT_AWARDY-mAbs Therapeutics, Inc.25 0800.00 USD
détention directe
30 juin 2025GRANT_AWARDY-mAbs Therapeutics, Inc.33 4500.00 USD
détention directederiv
17 juin 2025GRANT_AWARDRapport Therapeutics, Inc.21 8500.00 USD
détention directederiv
05 juin 2025GRANT_AWARDBioAge Labs, Inc.22 0000.00 USD
détention directederiv
25 avr. 2025GRANT_AWARDNatera, Inc.142—
détention directe
31 janv. 2025GRANT_AWARDNatera, Inc.114—
détention directe
25 oct. 2024GRANT_AWARDNatera, Inc.153—
détention directe
27 sept. 2024CONVERSIONBioAge Labs, Inc.1 638 236—
indirect· Sofinnova Venture Partners XI, L.P.
27 sept. 2024PURCHASEBioAge Labs, Inc.588 88818.00 USD
indirect· Sofinnova Venture Partners XI, L.P.
27 sept. 2024PURCHASEBioAge Labs, Inc.26 49718.00 USD
indirect· CRESTLINE SUMMIT PINNACLE MASTER, L.P.
27 sept. 2024PURCHASEBioAge Labs, Inc.18 35318.00 USD
indirect· CRESTLINE SUMMIT MASTER, SPC - CRESTLINE SUMMIT APEX SP
27 sept. 2024PURCHASEBioAge Labs, Inc.21 81418.00 USD
indirect· Crestline Summit Master, SPC - PEAK SP
27 sept. 2024PURCHASEBioAge Labs, Inc.11 11318.00 USD
indirect· Sofinnova Synergy Master Fund LP
27 sept. 2024CONVERSIONBioAge Labs, Inc.7 310 796—
indirect· Sofinnova Venture Partners XI, L.P.deriv